Data Analytics and AI are Accelerating Medical Research - Dr. Julie Panepinto, Director of the Di...

The TechEd Podcast
5 Mar 202444:06

Summary

TLDRIn this insightful podcast episode, Dr. Julie Panepinto, Director of the Division of Blood Diseases and Resources at the National Institutes of Health, shares her inspiring journey and the remarkable advancements in medical research. She delves into the pivotal role of data, artificial intelligence, and predictive analytics in revolutionizing healthcare, enabling early intervention and personalized treatment. Emphasizing the importance of qualitative patient experiences, Dr. Panepinto highlights how integrating objective data with individual goals can optimize outcomes. The conversation also explores the exciting future of healthcare, where technology empowers compassionate care, lifelong learning, and boundless scientific curiosity to improve lives.

Takeaways

  • ๐Ÿ˜ท The National Institutes of Health (NIH) oversees and funds biomedical research in various disease areas, including blood disorders, through the National Heart, Lung, and Blood Institute (NHLBI).
  • ๐Ÿงฌ Recent advancements in blood disorder research include understanding stem cells, their environment, aging's impact on blood cells, inflammation's role, and the explosion of patient data from imaging, genomics, and electronic health records.
  • ๐Ÿค– Artificial Intelligence (AI) and machine learning can help predict disease risk, identify ideal treatment candidates, and guide personalized care based on patient data and preferences.
  • ๐Ÿ“ˆ Incorporating patient-reported outcomes and qualitative measures of well-being alongside quantitative data can lead to better shared decision-making and tailored treatments.
  • ๐Ÿ” Scientific curiosity, quantitative thinking, and actively listening to patients are essential traits for researchers advancing discoveries in blood disorders and other medical fields.
  • ๐ŸŒ Interdisciplinary collaboration, data sharing, and partnerships between academia, industry, and government agencies can accelerate scientific progress and translation to clinical care.
  • ๐Ÿ”ฌ Medical research offers opportunities for young people to make a lasting impact on human health by exploring unanswered questions and driving new discoveries.
  • ๐Ÿซ Passionate educators who can ignite enthusiasm for science and encourage students to think bigger can inspire the next generation of medical researchers.
  • ๐Ÿš€ Advancements in precision medicine, data synthesis, and AI-driven decision support at the point of care are expected to transform healthcare delivery in the coming years.
  • ๐Ÿ‘ฉโ€โš•๏ธ While technology will play a growing role, maintaining the human connection, empathy, and personalized care during in-person patient visits will remain crucial in healthcare.

Q & A

  • What is the role of the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI)?

    -The National Institutes of Health is responsible for leading biomedical research in the United States and globally. Within the NIH, the National Heart, Lung, and Blood Institute focuses on advancing scientific discoveries related to heart, lung, and blood diseases.

  • What does Dr. Julie Panepinto oversee as the director of the Division of Blood Diseases and Resources at the NHLBI?

    -As the director, Dr. Panepinto oversees a staff of about 30 people who help the external community in the field of blood disorder research to submit grant proposals, obtain funding, and advance scientific discoveries.

  • What types of data are researchers gathering in the field of blood disorders?

    -Researchers are gathering various types of data, including imaging data (e.g., blood cell imaging), patient data (e.g., electronic health records), and genomic or "omics" data related to cells and biological processes.

  • How can artificial intelligence (AI) and machine learning be applied in the field of blood disorders?

    -AI and machine learning can be used for predictive risk modeling, helping to identify individuals at high risk for complications or adverse events, and informing decisions about preventive or curative therapies. Additionally, these technologies can assist in analyzing large datasets and identifying patterns that may lead to new insights.

  • What is the importance of patient-reported outcomes in blood disorder research?

    -Patient-reported outcomes, such as surveys measuring pain, physical functioning, and well-being, provide valuable qualitative data that can complement objective clinical data. This information helps researchers and clinicians understand the patient's experience and make more informed treatment decisions aligned with the patient's goals and preferences.

  • How does Dr. Panepinto envision the future of healthcare with the integration of data and AI?

    -Dr. Panepinto envisions a future where healthcare providers have access to synthesized and actionable information at the bedside, integrating data from various sources and leveraging AI to provide personalized, precision medicine tailored to each patient's profile and preferences, while still maintaining the importance of face-to-face interactions and compassionate care.

  • What character traits does Dr. Panepinto recommend for aspiring researchers in the field of healthcare?

    -According to Dr. Panepinto, some essential traits for aspiring researchers include scientific curiosity, a quantitative mindset with a fondness for data and evidence, and the ability to actively listen to patients and learn from their experiences.

  • What advice does Dr. Panepinto have for educators in inspiring the next generation of healthcare professionals?

    -Dr. Panepinto advises educators to share their excitement and enthusiasm for science, as a single teacher can spark a lifelong passion in a student. Maintaining that energy and making the subject fascinating can draw students in and inspire them to pursue careers in healthcare.

  • If Dr. Panepinto could go back in time and give advice to her younger self, what would it be?

    -If she could go back in time, Dr. Panepinto would advise her younger self to "think bigger" and not be afraid to push herself out of her comfort zone, as she came to realize the incredible opportunities and potential for accomplishment later in her career.

  • What are some of the benefits and challenges of incorporating patient data and AI in healthcare?

    -The benefits include the ability to personalize treatment plans, predict potential complications, and make more informed decisions based on vast amounts of data. However, challenges include ensuring data quality, addressing potential biases in data or algorithms, and maintaining the human element of compassionate care alongside technological advancements.

Outlines

00:00

๐Ÿ‘จโ€๐Ÿ”ฌ Introduction and Background

Matt Kirner introduces the guest, Dr. Julie Panipinto, the director of the Division of Blood Diseases and Resources at the National Heart, Lung, and Blood Institute of the National Institutes of Health. They discuss Dr. Panipinto's career journey and the influences that led her to pursue medicine, including her family background and early experiences in science.

05:02

๐Ÿ” Research Funding and Extramural Focus

Dr. Panipinto explains her role in overseeing the funding of external research in the field of blood disorders. She discusses the process of grant funding, collaborations with other agencies, and the responsibility to educate the public. She highlights the Institute's focus on supporting research in classical hematology, excluding blood cancers.

10:03

๐Ÿงฌ Current State of Blood Disease Research

Dr. Panipinto discusses the current advancements in blood disease research, including the study of stem cells, their environment, and the impact of aging on blood disorders and cardiovascular risk. She also mentions the explosion of data, including genomic and patient health record data, and the potential for utilizing this information to improve health outcomes.

15:04

๐Ÿ“Š Integrating Qualitative and Quantitative Data

The conversation explores the importance of incorporating both objective, quantitative data and subjective, qualitative data, such as patient-reported outcomes, in medical research and clinical practice. Dr. Panipinto highlights the value of understanding patients' experiences and preferences in shared decision-making and personalized treatment approaches.

20:05

๐Ÿค– Role of Artificial Intelligence in Medical Research

Dr. Panipinto discusses the potential of artificial intelligence (AI) in medical research, including predictive risk modeling, identifying ideal candidates for curative therapies, and incorporating various data sources to optimize patient care. She emphasizes the need for more data to develop robust AI algorithms and the importance of addressing potential biases.

25:08

๐Ÿ“ˆ Future of Healthcare and Precision Medicine

Looking towards the future of healthcare, Dr. Panipinto envisions a more personalized and synthesized approach to patient care, enabled by advances in technology and data integration. She highlights the potential for care providers to have access to comprehensive patient information at the bedside, facilitating more tailored and efficient treatment plans.

30:08

๐Ÿ‘ฉโ€๐Ÿ”ฌ Advice for Young Researchers and Medical Professionals

Dr. Panipinto reflects on the qualities and character traits that are essential for aspiring medical researchers, such as scientific curiosity, quantitative thinking, and the ability to listen to patients. She emphasizes the importance of keeping an open mind, thinking bigger, and being driven by the desire to improve people's health through scientific discovery.

35:08

๐Ÿ‘ฉโ€๐Ÿซ Advice for STEM Educators

Dr. Panipinto offers advice to STEM educators, highlighting the impact they can have in inspiring and fostering enthusiasm for science among students. She encourages educators to share their excitement and passion for the subject matter, as a single educator can spark a lifelong interest and pursuit in a field like medical research.

40:09

๐Ÿ”ฎ Advice to Her Younger Self

When asked what advice she would give her younger self as a high school student, Dr. Panipinto suggests thinking bigger and pushing beyond comfort zones. She emphasizes the importance of embracing discomfort and expanding one's horizons to achieve greater accomplishments and impact in life.

Mindmap

Keywords

๐Ÿ’กSTEM

STEM stands for Science, Technology, Engineering, and Mathematics. In the context of the video, the focus is on promoting and securing the American dream for the next generation of workforce talent in these fields. The script emphasizes the importance of STEM education as a foundation for innovation and development, particularly in technology and engineering, which are crucial for future advancements and job creation.

๐Ÿ’กTeched Podcast

The Teched Podcast, as mentioned in the script, is a platform that discusses topics related to securing the American dream for the next generation of STEM and workforce talent. It serves as a medium to share knowledge, insights, and developments in the field of technical education, emphasizing the importance of STEM education and its impact on career opportunities and technological advancements.

๐Ÿ’กNational Institutes of Health (NIH)

The National Institutes of Health (NIH) is referenced in the script as an important institution where Dr. Julie Panipinto serves. The NIH is a part of the U.S. Department of Health and Human Services and is the nation's leading medical research agency. It plays a crucial role in discovering new treatments, medications, and technologies to improve health and save lives, highlighting the importance of research in advancing medical science.

๐Ÿ’กBlood Disorders

Blood disorders are mentioned in the script as the focus of Dr. Julie Panipinto's work at the NIH. These conditions affect the body's ability to perform essential functions such as oxygen transport, clotting, and fighting infections. The script highlights the significance of research and funding in understanding, treating, and managing blood disorders, showcasing the critical role of medical science in enhancing patient care and outcomes.

๐Ÿ’กResearch Funding

Research funding, as discussed in the video script, is crucial for supporting scientific investigations, particularly in the field of medical research on blood disorders. The script explains how the NIH allocates budget and grants to support external community research, emphasizing the importance of financial resources in advancing scientific discoveries, developing new treatments, and improving healthcare outcomes.

๐Ÿ’กPredictive Modeling

Predictive modeling is a key concept in the script, particularly in the context of medical research and patient care. It involves using statistical techniques and data analysis to make predictions about future outcomes. The script highlights its application in identifying patients at risk of developing certain conditions, allowing for early intervention and personalized treatment plans, illustrating the integration of data science and technology in modern healthcare.

๐Ÿ’กGene Therapy

Gene therapy is mentioned in the script as a significant advancement in the treatment of blood disorders like sickle cell disease. It involves modifying or replacing defective genes to cure or alleviate diseases. The script reflects on the transformative potential of gene therapy in offering curative options for previously untreatable conditions, underscoring the impact of cutting-edge research and technology in medicine.

๐Ÿ’กArtificial Intelligence (AI)

Artificial Intelligence (AI) is highlighted in the script as playing a pivotal role in advancing medical research and healthcare. AI technologies are used for data analysis, predictive modeling, and even diagnosis and treatment planning. The script underscores the potential of AI to revolutionize healthcare by making it more personalized, efficient, and effective, showcasing the intersection of technology and medicine.

๐Ÿ’กPrecision Medicine

Precision medicine is a concept discussed in the script, referring to the customization of healthcare, with medical decisions and treatments tailored to individual patients. This approach often involves considering genetic, environmental, and lifestyle factors. The script points out how advancements in research, such as AI and predictive modeling, are paving the way for precision medicine, enhancing the effectiveness of treatments and improving patient outcomes.

๐Ÿ’กCareer in Medical Research

The script encourages considering a career in medical research, highlighting its importance in advancing healthcare, discovering new treatments, and improving patient outcomes. It emphasizes the role of curiosity, scientific inquiry, and the desire to make a difference as key traits for success in this field. Through the example of Dr. Julie Panipinto's career journey, the script illustrates the impact individuals can have in medical science and the fulfillment derived from contributing to meaningful advancements.

Highlights

Dr. Julie Panepinto discusses her background and inspiration for a career in medicine, including the influence of her grandfather, a general practitioner, and her father, a cardiologist.

Dr. Panepinto emphasizes the importance of mentors and support systems, such as her spouse, in advancing her career.

She describes her role overseeing the external community's research on blood disorders at the National Heart, Lung, and Blood Institute, including funding, education, and public outreach.

Dr. Panepinto discusses the advancements in understanding stem cells, their environment, and the impact of aging on blood disorders and cardiovascular risk.

She highlights the explosion of data in the medical field, including genomic data, electronic health records, and the potential for artificial intelligence and machine learning to analyze this data.

Dr. Panepinto explains the value of patient-reported outcome measures in capturing the patient experience and well-being, which can be incorporated into electronic health records.

She discusses the role of imaging and predictive modeling in diagnosis and risk assessment, and the potential for artificial intelligence to aid in these areas.

Dr. Panepinto envisions a future where healthcare providers have access to synthesized information at the bedside, enabling personalized and precision medicine.

She emphasizes the importance of maintaining a human connection and listening to patients, even as technology advances.

Dr. Panepinto advises young people interested in medical research to be curious, quantitative thinkers, and good listeners, as these traits are essential for advancing scientific discovery.

She encourages educators to share their excitement and enthusiasm for science, as this can inspire students to pursue careers in the field.

Dr. Panepinto reflects on the advice she would give her younger self, which is to think bigger and push beyond her comfort zone.

She discusses the role of artificial intelligence in predictive modeling for chronic diseases like sickle cell disease, which could help identify ideal candidates for curative therapies before end-organ damage occurs.

Dr. Panepinto emphasizes the importance of incorporating patient preferences and goals into treatment decisions, as these can influence the optimal course of action.

She highlights the potential for artificial intelligence to synthesize and present information in an actionable way, enabling healthcare providers to spend more time interacting with patients.

Transcripts

play00:00

securing the American dream for the next

play00:02

generation of stem and Workforce Talent

play00:05

my name is Matt kirner I am your host

play00:07

for the teched podcast you know we talk

play00:10

about that every week in our intro we

play00:12

talk about securing the American dream

play00:13

for the next generation of stem and

play00:16

Workforce Talent of course here at the

play00:17

tech IDE podcast we love stem we love

play00:20

stem education that of course standing

play00:22

for science technology engineering and

play00:25

math but if we're being honest we

play00:28

probably spend a little more time on the

play00:30

two middle letters that being the T and

play00:32

the E the technology and the engineering

play00:35

then perhaps we do on the science topic

play00:38

that all changes on this week's episode

play00:40

of the teched podcast we're really

play00:42

really honored and happy to welcome in

play00:44

to the studio of the teched podcast Dr

play00:47

Julie panipinto and Julie is the

play00:49

director of the division of blood

play00:51

diseases and resources at the national

play00:54

heart lung and Blood Institute of the

play00:57

National Institutes of Health yes I had

play00:59

to read that entire title that is an

play01:01

incredibly awesome title Dr panipinto

play01:04

we've been friends a long time I'm

play01:05

comfortable calling you Julie and it's

play01:07

my pleasure to welcome you to the teched

play01:08

podcast thank you Matt it's wonderful to

play01:10

be here glad to be able to share so what

play01:13

an incredible career you've had and and

play01:16

continue to have and and just want to as

play01:18

we familiarize our audience with the

play01:20

amazing work that you're doing want to

play01:21

give them a little bit of a sense for

play01:23

how you got into the world of medicine

play01:25

in the first place tell us what inspired

play01:27

you toward your current career sure I

play01:29

love that so I grew up in a family of

play01:31

Physicians my dad's dad so my

play01:34

grandfather was a general practitioner

play01:36

so did everything from delivering babies

play01:38

to taking out appendix to just taking

play01:40

care of a common cold so I can remember

play01:44

distinctly you know spending time with

play01:46

him and learning about medicine and then

play01:48

my father who was a cardiologist and

play01:50

getting to Shadow him in medical school

play01:53

so I really I had the influence in my

play01:55

family so that's probably first and

play01:57

foremost but I loved the science and I

play01:59

can remember

play02:00

kind of in a weird way dissecting a frog

play02:03

in biology and that's where I was like

play02:05

oh this is kind of not my thing to look

play02:07

at frogs but I love the concept of

play02:10

what's involved with um you know how the

play02:13

body works and so really that science is

play02:16

what continued to lead me down the path

play02:18

knowing what the profession looked like

play02:20

as a whole from the family

play02:22

influence know you're taking me back in

play02:24

time to my time in high school

play02:25

dissecting a fetal pig actually that was

play02:27

an experience that I will never forget

play02:29

wasn't inspired quite on the same career

play02:31

pathway that that you were certainly

play02:33

having that medical background in your

play02:35

family your grandfather and your father

play02:37

I won't make the obvious ton that

play02:39

medicine was in your blood because we'll

play02:40

be talking about blood a lot in this in

play02:43

this particular episode such an

play02:44

incredible influence that our mentors

play02:46

can have on us whether that's parents

play02:48

whether it's teachers whether it's some

play02:50

other individual in our life in your

play02:51

case your father and your grandfather

play02:53

I've got a believe there were other

play02:54

major influences as well any that come

play02:56

to mind absolutely so you know as other

play03:00

professional women um have really

play03:02

written a lot about you really are about

play03:04

your plus one and so for me that's been

play03:06

my spouse David brusso who also happens

play03:08

to be in medicine as a leader in

play03:10

medicine but clearly you know um without

play03:14

his support not only professionally but

play03:16

personally for our family I wouldn't

play03:17

have been able to make the big move

play03:19

geographically and um really just at

play03:22

that point in my career and

play03:24

so and my decisions in my career clearly

play03:29

influences his career development too so

play03:31

this was really an incredible incredible

play03:33

display of support that um allowed me to

play03:36

Advance my career in leadership at that

play03:38

point in time what a what a great

play03:40

opportunity what a what a great marriage

play03:42

and for sure I mean having the support

play03:43

of your spouse is absolutely unequivocal

play03:46

in terms of where your career goes and

play03:48

making sure that goals remain aligned

play03:50

and that families remain productive and

play03:52

and that that part of our life is so

play03:54

very important I agree 100% I'll also

play03:56

Echo your sentiment so full disclosure

play03:59

uh your husb husband Dr David brusso is

play04:00

one of my best friends and somebody I've

play04:03

known a long long time and there's no

play04:04

better person or character on the planet

play04:06

you're fortunate to have him as a

play04:08

husband I'm fortunate to have him as a

play04:10

friend and I I really appreciate you

play04:11

taking a moment to highlight David as

play04:13

well tell us a little bit about why you

play04:15

took that step from you know kind of

play04:16

more of the patient care side to the to

play04:18

the research side at the national level

play04:20

yes so I think that was it's probably

play04:22

multifactorial one was first and

play04:24

foremost personally my children were

play04:27

more or less grown and they were on

play04:29

their well on their way to Independence

play04:32

um having left high school so where I

play04:33

was grounded as far as geographic

play04:36

location um didn't matter as much from

play04:39

my professional standpoint and then

play04:42

professionally I you know I loved my job

play04:44

of taking care of patients loved being

play04:46

able to do research but uh as I

play04:49

continued on my career I was looking for

play04:51

more leadership looking for something to

play04:53

continue to challenge me and this

play04:56

position here included not only the

play04:59

ability to stay involved in science it

play05:01

brought a whole new challenge of being

play05:03

involved in a in a very different way um

play05:05

and broaden my connection to science to

play05:08

not only um pediatric blood disorders

play05:11

but to really all of blood science so

play05:13

it's been a wonderful pivot and I

play05:15

learned something new at least a few

play05:17

times a day and I love that um and it

play05:20

you know really has worked out well so

play05:22

really speaks to the advantage of being

play05:24

in a in a career where you you are

play05:26

learning new things every day and I

play05:28

think that's as we kind spend time in

play05:30

this era of lifelong learning and more

play05:32

and more individuals are realizing that

play05:34

you know what we might have learned 10

play05:35

or 20 or 30 years ago isn't going to

play05:37

carious necessarily through an entire

play05:39

career and really having that that

play05:41

Curiosity and that excitement and energy

play05:43

around learning really really important

play05:45

as especially as you're entering or have

play05:48

entered into this this role that you're

play05:49

in now Julie we talked about dissecting

play05:52

frogs we talked about dissecting fetal

play05:54

Pigs we're going to dissect your title a

play05:56

little bit because as I as I introduced

play05:57

you to our audience early on it was

play05:59

there's a lot of things going on there

play06:01

and so let's talk a little bit about

play06:02

everything you're doing just started by

play06:04

the National Institutes of Health what

play06:06

should our audience know about the work

play06:08

at that level and then we'll dive down a

play06:10

little bit deeper into some of the work

play06:12

that you're doing surely so the National

play06:14

Institutes of Health is really charged

play06:16

with really leading biomedic research

play06:19

for the country and even globally So

play06:23

within that there are multiple

play06:25

institutions largely div divided by

play06:28

maybe the diseases that they Encompass

play06:30

so for our Institute the heart lung and

play06:32

Blood Institute we um think about

play06:36

research and want to advaned scientific

play06:38

discovery in those areas and then if we

play06:41

think about it what I oversee which is

play06:43

the blood division of the heart lung and

play06:44

Blood Institute we oversee um what we

play06:48

call extramural and extramural means our

play06:50

external community so the external

play06:52

community's uh focus in blood disorder

play06:55

research that's based in classical

play06:58

hematology so doesn't involve blood

play07:00

cancer which would go to our National

play07:02

Cancer Institute so that encompasses a

play07:05

lot because blood sort of is everywhere

play07:07

we like to say and very important part

play07:09

of our um existence and so my job is to

play07:14

oversee about 30 staff who help our

play07:17

external Community um think about

play07:20

advancing science and blood disorders

play07:22

submitting their ideas to us for funding

play07:24

and then getting them to funding and

play07:26

getting them through the success of that

play07:28

of that Grant to Advanced scientific uh

play07:32

discoveries so if we walk our audience

play07:34

through that a little bit we've got the

play07:35

National Institutes of Health and then

play07:37

and then underneath that if you will the

play07:39

National heart lung and Blood Institute

play07:41

and then as a part of that the division

play07:43

of blood diseases and resources of which

play07:45

you are the director you you mentioned

play07:48

funding you mentioned you know this

play07:50

extra mural just give us a little bit

play07:51

more of a sense for you're overseeing

play07:53

the funding with these Partners is that

play07:55

a big part of what you do so we have a

play07:57

budget every year that is and it's

play07:59

really appropriated by Congress and with

play08:01

that budget we then utilize that money

play08:05

to

play08:06

Grant fund grants in the blood disorder

play08:09

space um so that's really sort of how it

play08:11

works we do have some partnership with

play08:14

um other federal agencies where we

play08:16

collaboratively work side by side so CDC

play08:18

for instance where we're working in

play08:20

complimentary spaces and we're trying to

play08:22

further Discovery Science um with CDC

play08:25

who's doing surveillance work or

play08:27

populationbased work so that's just one

play08:28

example of partnering we also are

play08:31

charged with educating so educating

play08:33

others in Scientific careers in blood

play08:36

disorders and trying to keep that um

play08:39

kind of career pathway going in addition

play08:41

we also have a responsibility to the

play08:43

public so making sure we're educating

play08:45

the public not only about the research

play08:46

discoveries in the blood disorder space

play08:48

but also on the diseases that we serve

play08:51

plenty of things to keep you busy

play08:52

without question and when we think about

play08:53

funding and we talk a lot um more on the

play08:55

education side probably in the case of

play08:57

the teched podcast with R1 research

play09:00

institutions and so on um that are

play09:02

performing research in a wide wide

play09:03

variety of different Endeavors is the

play09:05

research both private and public you're

play09:07

partnering with with both types of

play09:08

entities or tell us about that a little

play09:10

bit so we largely Grant I would say the

play09:13

large majority of our grants go to uh

play09:17

institutions that are public not for

play09:18

profit right so academic institutions

play09:21

that's where most of our scientists

play09:23

reside we do have a very strong

play09:25

portfolio and what's called the small

play09:27

business grant so there is um

play09:29

specific grant opportunities for small

play09:31

businesses to submit their work often

play09:34

partnering with these same academic

play09:36

institutions or investigators from those

play09:37

places to fund Grant and scientific

play09:41

ideas that we hope we supporting kind of

play09:43

the next step to make those what we say

play09:46

commercialize those discoveries so

play09:48

that's a really nice um also sort of

play09:51

partnering with small businesses

play09:53

absolutely so a little bit of both more

play09:54

so on the public side more so on the

play09:56

nonprofit side and on the academic side

play09:58

but but certainly opportunities for for

play10:00

both public and private let's dive in a

play10:02

little bit deeper into some of the work

play10:04

you're doing with regard to let's just

play10:05

say the current state of research so

play10:07

when you think Julie about you know

play10:09

advancements in the field of blood

play10:10

diseases what are some insights that

play10:11

would be interesting to our audience

play10:13

yeah so we largely deal with blood

play10:15

diseases that are are rare but through a

play10:18

lot of the bench research we we call

play10:20

that our basic science research we've

play10:22

learned a lot about the stem cell so the

play10:25

stem cell is what's made in your bone

play10:27

marrow that goes on to make all of your

play10:28

other blood cells and we're learning a

play10:30

lot about the environment that that stem

play10:32

cell has to live in over time we're

play10:34

learning the impact of aging and we're

play10:36

learning how that can influence not only

play10:39

the development sometimes of blood

play10:41

disorders that are malignant cancers but

play10:43

also how that might impact um what we

play10:46

call cardiovascular risk so risk to your

play10:48

heart so we're learning a ton about the

play10:50

blood cell I think we also are learning

play10:51

a lot about inflammation so we know that

play10:54

inflammation in the body can also um

play10:57

lead to Chronic chronic disease we think

play11:00

to to have constant inflammation in the

play11:02

body right so that's also largely driven

play11:05

by many of the things we study in the

play11:07

blood space right so the blood

play11:09

biomarkers can sometimes um suggest a

play11:12

state of inflammation or even some of

play11:13

the diseases that we take care of can be

play11:15

pro-inflammatory diseases just by the

play11:17

nature of how they involve the immune

play11:19

system so those are just a flavor of

play11:21

some of the things from the basic

play11:23

science aspect but we've also um as you

play11:26

might imagine are in an an explosion of

play11:28

data so data not only from what we call

play11:31

the cell so sort of genomic or omix data

play11:33

which is very much at the bench but all

play11:36

the way to a patient who when they enter

play11:38

a healthcare system with electronic

play11:40

health record data every data point

play11:43

there is information that potentially

play11:45

could be utilized to help improve their

play11:47

health outcomes we love data we talk all

play11:50

the time about it in God we trust all

play11:51

others bring data we talk about data

play11:54

analytics artificial intelligence

play11:55

machine learning just the the vast

play11:57

amounts of data now that we have have

play11:59

available to us and it really doesn't

play12:00

matter what part of the economy we're in

play12:03

we talk about data in the energy space

play12:05

in the agriculture space National

play12:07

Defense certainly in manufacturing I

play12:09

mean just Gathering tons and tons of

play12:11

data some cases just for the sake of

play12:13

gathering the data and hoping we can do

play12:15

something with it later but obviously

play12:17

the goal is for us to use that data to

play12:18

analyze it and then to to move forward

play12:21

toward a goal so I want to get into that

play12:22

just a little bit Julie and talk about

play12:25

um you know the incredible amounts of

play12:26

patient data that I know you have to be

play12:28

gather in and that the world of medicine

play12:30

has to be gathering in general so what

play12:32

are the kinds of data that researchers

play12:34

are gathering in their work on blood

play12:36

disorders and then how is all of this

play12:38

data managed and and analyzed great

play12:41

question so I think one of the areas

play12:43

probably common to most of medicine and

play12:45

that's really probably been at the

play12:47

Forefront is Imaging so in the blood

play12:49

disorder space Imaging uh that can help

play12:52

us detect blood cells that typically you

play12:55

know a human is looking under the

play12:56

microscope there are some automated ways

play12:59

that um came much before which probably

play13:01

is a form of sort of artificial

play13:03

intelligence but now I think we have the

play13:05

ability to also I don't want to say come

play13:08

to a diagnosis but more description uh

play13:11

for the clinicians to better understand

play13:14

what the blood smear might be suggesting

play13:17

so are those cancer cells that we see

play13:19

there so the type of cell in our world

play13:22

we think about things like the cell

play13:24

suggest an underlying genetic anemia

play13:27

based on what they look like

play13:29

and then it it's also good at

play13:31

quantifying so the amount of the cells

play13:34

so does it suggest you have too low of a

play13:36

white count or too low of a a platelet

play13:38

count or a a red cell count which can

play13:40

lead to blood disorders so that's a

play13:42

pretty cool thing that I think is true

play13:44

and almost any uh field is the Imaging

play13:47

there's lots of Imaging already

play13:48

available that um can be put through

play13:52

algorithms to help with diagnosis and I

play13:55

think the other piece is the patient

play13:56

which I touched on that a little bit is

play13:57

so the patient Rec Rec in and of itself

play14:00

and so I think the way that's probably

play14:02

already in play is in a predictive

play14:04

modeling standpoint so we can we take

play14:06

information on the hundreds or thousands

play14:09

of patients that have come before the

play14:11

individual at hand in front of the

play14:12

physician and help that physician

play14:15

understand um risk for certain things

play14:19

and and we can talk about the

play14:20

cardiovascular risk profile it might

play14:22

include lab values like your cholesterol

play14:24

it might include your age your family

play14:26

history and to kind of put together a

play14:28

profile that suggests you may or may not

play14:30

be at higher risk for certain diseases

play14:32

and then even better suggests potential

play14:36

preventive measures that could pre lower

play14:39

that risk right so if we talk again

play14:41

about cardiovascular because it's an

play14:42

easier space than blood disorder uh for

play14:45

this it may be exercise it may be diet

play14:47

it may be those easy things or it could

play14:49

even be a preventive

play14:50

medication so I think it's really pretty

play14:53

neat it's more um as you might imagine

play14:57

it's the computer's acting a bit as a

play14:59

brain but it doesn't have the ability to

play15:02

have that cognitive

play15:04

um it it it's as good as what is fed to

play15:07

it and so some of the worry is always

play15:09

that we have to make sure it gets all of

play15:11

the information it might need for the

play15:13

patient at hand without question you

play15:15

know and I just can't help but draw

play15:17

parallels again into my world of

play15:19

advanced manufacturing and we talk all

play15:20

the time about uh you know putting

play15:22

sensors on a piece of manufacturing

play15:24

equipment a robot for example so we can

play15:26

measure things like force and

play15:27

disturbances and temperature and

play15:29

moisture all kinds of you know torque

play15:31

things like things like that so we

play15:32

censor up a robot and it's not just that

play15:35

one robot that we're censoring it's it's

play15:37

you know thousands if not tens or

play15:39

hundreds of thousands of robots um and

play15:41

Gathering all that data it's really the

play15:43

same way my wife Renee who you know well

play15:46

and I had the opportunity back in um in

play15:49

the month of November of last year to

play15:51

ride in a wh car in Phoenix so we

play15:53

literally we called an Uber and uh right

play15:56

on the Uber app it said are you okay

play15:57

riding in an autonomous vehicle and we

play15:59

kind of looked at each other we're like

play16:00

well we're in a hurry we have to get

play16:01

where we're going fine we'll say yes and

play16:03

literally this this autonomous vehicle

play16:06

drives up picks us up at the meeting we

play16:08

were at to take us over to a Convention

play16:10

Center there's lit there's no driver in

play16:12

the car we're in the backseat of this

play16:13

car and it's driving itself it was it

play16:15

was somewhat unnerving but the reason

play16:17

that works is because you know that car

play16:20

is driving around looking at what's a

play16:21

stop sign what is traffic what's weather

play16:24

you know all of this data sending it up

play16:26

to the cloud and then all that data is

play16:27

going to every other wayo car and then

play16:30

every wayo car is sending the same data

play16:31

up to the cloud and back down to our car

play16:33

and in real time our car gets as smart

play16:35

as all the cars put together in the same

play16:37

way that a robot using sensor data and

play16:40

artificial intelligence can predict its

play16:41

own future failure and Order its own

play16:43

replacement parts before the failure

play16:45

ever happens and what I'm hearing is

play16:47

we're really doing the same thing in

play16:48

medicine where if we can take data from

play16:52

thousands if not hundreds of thousands

play16:53

of patients and gather all that data and

play16:57

analyze it using artificial icial

play16:58

intelligence using machine learning find

play17:00

patterns in the data that's going to

play17:02

give us a much better opportunity to

play17:05

predict a you know potential potential

play17:07

future issue or maybe to diagnose a

play17:09

current issue than we would have

play17:11

otherwise been able to do provided as

play17:13

you point out I think rightly so that

play17:15

the quality of the data and the way

play17:16

we're using it is is being approached in

play17:18

the right way as well and that we're

play17:20

driving out things like bias that can

play17:22

result if we use the wrong wrong data or

play17:24

if that if we improperly train a machine

play17:26

learning algorithm we can we can have

play17:28

all kind of bad outcomes so making sure

play17:29

we've got Integrity in that process as

play17:31

well I know that was kind of a long

play17:33

explanation in in my world of how all

play17:35

this is working but am I getting it

play17:36

about right absolutely it's pretty

play17:39

exciting yeah it's really really

play17:40

exciting so let's keep going now we've

play17:41

got the the data right so we can look at

play17:43

Digital Data ones and zeros picking up

play17:46

you know numerical data Trend data all

play17:48

these other things really that's only

play17:51

half the equation right we have this

play17:52

other qualitative side of things so what

play17:54

are the what is the patient experience

play17:56

what are the reported outcomes talk a

play17:58

little a little bit about that

play17:59

qualitative side in terms of the

play18:01

research that that you and others are

play18:02

doing sure I love that because my

play18:04

background was in really trying to

play18:06

research that partly because the disease

play18:08

I studied which was Clea disease uh most

play18:11

common manifestation of that is pain and

play18:13

so how does one measure pain there

play18:16

aren't uh true biomarkers really that

play18:19

that help support that so you really

play18:21

need to and really should be asking the

play18:23

patient right to rate that for you or to

play18:26

uh share with you what that look like

play18:28

and so there's what I would say

play18:30

objective measures to measure what's

play18:32

really sort of someone's um own

play18:35

experience with pain and you do that

play18:37

with these patient reported outcome

play18:39

measures and so they're validated

play18:40

surveys that get at what I would say is

play18:42

the well-being which can include

play18:44

physical functioning might include

play18:45

social functioning and really just

play18:47

straight out measurement of how they

play18:49

experience pain how the individual

play18:51

experiences pain and then those are

play18:53

scored and those scores have meaning

play18:55

like any survey right that puts a score

play18:57

out and then the nice thing about that

play18:59

and this is happening already in

play19:00

electronic health records across many in

play19:02

healthcare institutions is that score is

play19:04

included in your medical record it can

play19:07

be graphed over time so you can see

play19:09

changes the physician can see that at

play19:11

the point of care that functioning maybe

play19:13

has dipped because the patient filled

play19:15

out that survey before the visit you can

play19:17

address that within the visit you know

play19:18

what's going on I see that you know

play19:21

you're not functioning as well let's

play19:23

share that so I think that's a really

play19:25

neat piece it's been a hard piece

play19:27

because not everyone has

play19:29

adopted uh collection of those tools but

play19:33

it definitely can be done and it's being

play19:34

done I would say probably in the cancer

play19:36

world and in the orthopedic World um

play19:39

much more than in other areas and in

play19:42

fact in the orthopedic world it's been a

play19:43

really neat tool to better predict um

play19:46

who might benefit from things like hip

play19:48

or knee replacement right given

play19:50

someone's current functioning what does

play19:51

that look like and will surgery versus

play19:53

just physical therapy help you perform

play19:56

better what and what will that requ

play19:58

recovery time look like so again more

play20:00

data I like to think of it as object of

play20:02

data but really representing the patient

play20:04

which is often missing from the story

play20:07

absolutely objective data and really

play20:09

when you know as I was listening to that

play20:11

that answer you know that qualitative

play20:13

side you know you know trying to you

play20:15

know quantify pain for example and

play20:17

certainly pain to one individual I'm

play20:19

guessing might not manifest itself or or

play20:21

be communicated in the same way that the

play20:23

pain for another human being might be

play20:25

and so you're really kind of comparing

play20:27

not just a you know an objective measure

play20:29

but really trying to understand to to

play20:31

your point um you know how that changes

play20:33

over time and maybe how an individual's

play20:36

responses relate to Prior responses that

play20:38

they that they might have offered and

play20:40

really making sure that we're not just

play20:41

turning this into let's gather all the

play20:44

data and have a really kind of uh you

play20:46

know basic uh and and heartless forgive

play20:49

the term approach to to how we're caring

play20:52

for a patient but but also making sure

play20:54

we're listening and paying attention to

play20:56

that qualitative data and then we have

play20:57

the question of okay now we have both

play20:59

right we've got the quantitative data

play21:02

sets and we can compare those to you

play21:04

know hundreds of thousands of patients

play21:06

we have the qualitative data how does

play21:08

somebody whether they're doing research

play21:09

or treating a patient bring the two of

play21:11

those together in a way that maximizes

play21:12

the benefits of both great question so I

play21:15

think maybe you're getting at in some

play21:17

ways this pre-existing data but it's

play21:19

data that can be collected over time and

play21:21

how do we incorporate both of them to

play21:23

better serve the individual to Advance

play21:26

Health outcomes I think one way and I

play21:29

mentioned this a little bit is um given

play21:32

an individual's preferences and this is

play21:34

really coming into shared

play21:36

decision-making there's often more than

play21:37

one way to treat a disorder or deal with

play21:40

a problem and so ideally the patient is

play21:44

weighing in on sort of what their

play21:46

preference might be and that preference

play21:48

can often get at what the most important

play21:51

goal is for them which might be returned

play21:53

to work for someone else it might be I

play21:54

want to run a marathon for an athlete it

play21:56

might be I want to be able to play right

play21:58

right so so the treatment Choice um what

play22:01

you're trying to maximize their care

play22:03

towards very much can be influenced by

play22:06

that that personal or qualitative piece

play22:09

um balanced with what you know in the

play22:11

long run might be I guess what I would

play22:13

say the more medical side of it is sort

play22:15

of

play22:16

optimizing their organ function at times

play22:19

or their ability to perform can be

play22:22

physiologic right so you'll know the

play22:23

physiologic piece that you need to

play22:25

optimize that you hope lines up with the

play22:28

same preferences for the patient right

play22:30

so that's maybe one way to think about

play22:32

it which I think is why you considering

play22:35

both pieces of that as you're examining

play22:38

scientific questions because I think the

play22:41

researcher can be blinded by what they

play22:44

think is the right way to do things the

play22:46

or the right way to fix something or

play22:49

cure something but without listening to

play22:51

what the patient might want from that

play22:54

can be quite mismatched it's interesting

play22:56

and quite quite honestly something I

play22:58

hadn't spent a lot of time thinking

play22:59

about myself which is yeah that plan

play23:01

could be different depending upon the

play23:03

ultimate goal of the patient and

play23:04

certainly every individual you know may

play23:06

want something different out of their

play23:08

care have a different goal be working on

play23:09

a different personal goal looking at a

play23:11

different outcome and making sure that

play23:13

we're we're listening to the the patient

play23:15

not just along the way but also in terms

play23:17

of hey what is the end game what is the

play23:19

goal here and and where do we want to go

play23:21

so really really important as we get

play23:23

more and more of this data um you know

play23:25

both qualitative and quantitative I want

play23:28

dive in a little bit deeper into the

play23:29

artificial intelligence side of things

play23:31

and this is something we we've talked

play23:33

about quite a bit here on the on the

play23:34

teched podcast we've had people using Ai

play23:37

and Sports Medicine we had a guest that

play23:40

talked about that pretty extensively we

play23:42

had a guest that was on talking about

play23:44

using artificial intelligence to teach

play23:46

young people uh how to optimally throw a

play23:48

baseball believe it or not and and we've

play23:50

had that all the way to people that have

play23:52

uh you know automated robotic systems

play23:55

with a backend AI platform to literally

play23:58

where you don't need an individual or a

play24:00

person programming the robot that's all

play24:02

done by artificial intelligence we know

play24:04

that that's happening in the world of

play24:06

medicine too so so talk a little bit

play24:08

more about the role that AI is playing

play24:10

in the work that you're doing and if

play24:12

there's specific breakthroughs or or

play24:14

applications that that you're really

play24:15

excited about Julie yeah I think I

play24:17

touched on predictive um risk modeling I

play24:20

think I'll use an example of Clea

play24:23

disease now that we have gene therapy

play24:26

that was approved last month by the FDA

play24:28

to different gene therapy approaches

play24:30

we've had bone marot transplantation

play24:32

which has also been a Curative option

play24:34

for individuals with Clea disease but

play24:36

limited by not having necessarily a

play24:38

donor for every individual but if we

play24:41

think about being able to

play24:43

predict who might experience these

play24:45

devastating complications and let's say

play24:47

stroke might be one of them you don't

play24:50

want to wait until the stroke happens

play24:52

because stroke already uh if a stroke

play24:54

has occurred it's already caused some

play24:56

degree of damage to the brain and some

play24:59

cognitive you know problems will arise

play25:02

from that so if we had a way to predict

play25:04

when an individual was I guess their end

play25:07

organs their brain their heart their

play25:09

lung their kidneys were you know not yet

play25:13

affected by the end organ disease could

play25:15

we offer these Curative therapies at

play25:18

that time period before right but the

play25:20

Curative Therapies in of themselves come

play25:21

with risk and so that's also some of

play25:25

what needs to go into what you'd call

play25:27

the predictive model of can we identify

play25:30

the ideal candidate can we identify the

play25:33

age before they develop end organ damage

play25:36

that we're trying to prevent and then

play25:38

present to the patient you know we think

play25:41

you're at the highest risk for a stroke

play25:43

we think you should consider these

play25:45

Curative therapies because we think that

play25:48

this will prevent that from happening if

play25:49

you have these Curative approaches now

play25:51

as a child as opposed to an adult that

play25:53

may be just one example even those that

play25:56

may experience uh pain for example we

play25:59

know once that happens that continues to

play26:01

happen

play26:02

so you know I think a risk model that

play26:05

incorporates all these risk factors

play26:07

could be extremely helpful um for

play26:10

individuals with something like cyle

play26:11

cell disease but applies to any chronic

play26:13

disease that wors over time when you

play26:15

think about um Ju Just the value of

play26:18

those Predictive Analytics is the term

play26:20

that we use here quite frequently on the

play26:21

Tech podcast and and and to your point

play26:24

really being able to sit down with a

play26:25

patient and saying here you know here's

play26:27

what we're dealing with here are the

play26:28

odds of this and here's a potential

play26:29

Curative therapy that could be helpful

play26:32

but there's risks associated with that

play26:33

and here are the odds of that here's

play26:35

what the data tells us and really um you

play26:38

know with a I would believe a pretty

play26:39

high degree of confidence be able to sit

play26:41

down and say here are the options and

play26:43

and let's pick the best one for you is

play26:44

that am I I know I'm simplifying it but

play26:46

is that is that what you're saying am I

play26:48

understanding that right correct and I

play26:50

think what we need is just a lot more

play26:52

data so we need a lot more data points

play26:53

over time right so we need to learn more

play26:56

about the secur therapies and how they

play26:58

impact a person's life and their end

play27:01

organs right and we need to learn much

play27:04

more about what data we have already to

play27:06

create the algorithms we're not there

play27:08

yet but we're getting there absolutely

play27:11

getting there and in really in every

play27:12

space throughout the economy I just

play27:13

think it's so exciting and we talk about

play27:15

some of the scary things related to Ai

play27:17

and you can't of course you know go

play27:19

online or or or read just about any new

play27:21

source which without hearing some of the

play27:23

you know scary horror stories and then

play27:25

you you have a conversation like this

play27:26

and you think about how how incredibly

play27:29

beneficial this can be to people's

play27:30

quality of life if we use it the right

play27:32

way we use it ethically we use it

play27:34

morally we we're thoughtful and

play27:36

intentional about how we use artificial

play27:37

intelligence and machine learning I

play27:39

think the future is really really bright

play27:40

and really really exciting speaking of

play27:42

that bright and exciting future I know

play27:43

you spend really a lot of time thinking

play27:45

about where is all this going so if we

play27:48

if we think for a minute about the

play27:49

future of healthcare and you've touched

play27:51

on this a little bit already but you

play27:52

know how would you let's say we turn the

play27:54

clock forward 10 15 20 years how is it

play27:56

going to feel different at that period

play27:57

of time than it does today well that's a

play28:00

great question because as you know our

play28:01

health care and our Health Care system

play28:03

is very complex right and so and there's

play28:05

this explosion of information so even

play28:08

when I trained I we probably had a

play28:10

little bit of genetics in my training

play28:12

but imagine how much since I trained

play28:14

that we've discovered and I've had to

play28:16

learn and keep up with so I think if we

play28:19

think about maybe some of as what I hope

play28:21

will happen is that there will be the

play28:24

ability really at the bedside with the

play28:26

patient for for the care provider to

play28:29

have all of the information they need at

play28:31

hand which they often have all the

play28:32

information but it's not synthesized

play28:35

it's not cated it's not put together in

play28:37

a way that then is actionable for them

play28:40

to you know provide the best care they

play28:42

can for that individual in front of them

play28:44

so that's a bit of like maybe Precision

play28:45

medicine right and we see this a little

play28:48

bit already with some of the care that's

play28:50

tailored based on you know let's say

play28:52

your your risk factors for cancer right

play28:54

we can detect some of that by doing some

play28:56

testing right but I think this is is

play28:57

even going further than that which is

play28:59

taking all of the information at hand

play29:01

based on every patient that came before

play29:03

you and based on your own profile and

play29:05

then right there in in real time being

play29:08

able to to serve that patient best so

play29:11

that's probably coming five years is

play29:12

probably very very optimistic but we're

play29:14

seeing it in

play29:15

pieces I I think that hopefully will

play29:18

help allow care providers to have more

play29:22

time to to Really interact with patients

play29:25

and to provide what I would say is more

play29:28

that the care I can remember my my

play29:30

grandfather providing which is you know

play29:32

he was able to do everything we can't do

play29:35

that anymore but I think there's that

play29:36

piece missing where having a care

play29:39

provider be able to sort of manage all

play29:41

of your care in a model that

play29:43

incorporates all of those Specialists

play29:45

could be really really helpful because I

play29:47

think as a patient your care can be

play29:49

pretty fragmented the way things are set

play29:51

up now I love the word that you used

play29:53

which is actionable which is all right

play29:54

data is fine AI is fine but unless we

play29:57

can have some kind of an outcome that

play29:59

says all right here's what we're going

play30:00

to do with that data it really isn't

play30:01

worth very much and so I like that word

play30:03

actionable and I and I like the whole

play30:05

idea that uh you know as we March toward

play30:08

the future that that the you know not

play30:10

just the quality of healthcare but also

play30:11

that interpersonal side of it um you see

play30:14

continuing to improve which I know is

play30:16

music to the years of our of our

play30:17

listeners and to many you know in as

play30:20

much as artificial intelligence machine

play30:22

learning all these different

play30:24

technologies that we're talking about

play30:25

today Julie are going to impact every

play30:27

every space in the economy of course

play30:29

including healthare you know what are

play30:30

the things that are going to stay the

play30:31

same what doesn't change as we head into

play30:33

this future face to face in-person

play30:37

visit I think is really key I I think

play30:40

there's a lot of advantages to tella

play30:42

Health interspersed with that but I

play30:45

think that really bedside connection

play30:48

is it's always going to have to be there

play30:51

that would be my answer to that

play30:53

absolutely well you know it's

play30:54

interesting as we again kind of turning

play30:56

back into the world that I spend a

play30:57

little bit more time in and talking

play30:59

about growing companies and growing

play31:00

businesses and and so on and we get the

play31:03

question a lot about well you know what

play31:04

roles are going to be really important

play31:05

in the future you know as as business in

play31:08

general adopts artificial intelligence

play31:10

machine learning chat Bots you know all

play31:11

these automated systems for interacting

play31:14

with clients and so on what is the

play31:16

future for some of the careers and in in

play31:18

particularly maybe Business Development

play31:19

people or sales people and in my opinion

play31:22

is those jobs become even more important

play31:23

and that we're never going to lose that

play31:25

need for interpersonal con action for

play31:27

compassion for empathy for you know

play31:29

people really taking an interest and

play31:32

caring about uh you know whether that's

play31:34

a customer or a patient in a way that

play31:36

technology is never going to be able to

play31:38

do on its own I think it's a really

play31:39

really interesting observation that you

play31:41

make thinking about all the the Myriad

play31:44

opportunities that young people have now

play31:46

as they think about their careers uh in

play31:48

specific even in healthcare I mean so

play31:50

many different avenues that they can

play31:53

travel down as they consider a career in

play31:54

healthc care with all of those out there

play31:57

Julie if you're counseling a young you

play31:59

know let's call it a high school student

play32:01

a junior senior maybe even somebody a

play32:03

little bit younger uh that's thinking

play32:04

about a career in healthcare why should

play32:06

they think about medical research why

play32:08

should that be part of at least one of

play32:10

the choices that they're considering

play32:12

yeah I love that so I think if you want

play32:14

an opportunity to really help people

play32:16

right so you see people who are ill and

play32:18

you may have even experienced it

play32:20

yourself or with a family member and you

play32:22

have that desire to be involved in that

play32:25

from the standpoint of you know what can

play32:27

I do to

play32:29

improve someone's health and so not only

play32:31

does that happen at the bedside with the

play32:33

tools that you have but it's very very

play32:35

important

play32:37

to to do research to improve what we

play32:42

know right so we've come look how far

play32:44

we've come right who would have thought

play32:45

that we could actually have Precision

play32:47

medicine where you might be able to

play32:49

better understand my own risk by doing a

play32:51

blood test right and then intervene

play32:54

before I develop that problem so it'll

play32:57

always be at the Cornerstone right and I

play33:00

remember telling my my boss at my former

play33:03

job my first boss there because he would

play33:05

always ask me about gene therapy you

play33:07

know I'd want to go in and talk about

play33:08

something else be like what about gene

play33:09

therapy and CLE cell Julie and this was

play33:11

25 years ago I'm like ah if I'm still

play33:14

alive and that happens you know then

play33:15

great and here we are today it happened

play33:17

in December so you know ever being The

play33:20

Optimist uh gene therapy is here right

play33:22

and I think it's going to it's it's life

play33:24

transformative and I was maybe not such

play33:26

a Bel

play33:27

way back then but look at how the field

play33:29

exploded so the possibilities are

play33:31

endless if you if you're a quantitative

play33:34

thinker and you like Discovery um and

play33:37

you connect with humans and disease and

play33:39

I think that's it's a path for you

play33:42

absolutely you know I mean as as you're

play33:44

chatting about that and I'm just

play33:46

thinking about number one the importance

play33:48

of keeping an open mind and and

play33:49

certainly I can think of things that

play33:50

we're doing today now in some of our

play33:52

businesses where if you had told me that

play33:53

was possible 25 years ago I would have

play33:55

told you that that you were crazy and

play33:57

the examples are almost endless I won't

play33:58

even try and fathom or bring them all up

play34:00

but but such a different world that

play34:02

we're living in today so part of what

play34:03

I'm hearing in that last response is hey

play34:05

keep an open mind and make sure that

play34:07

that we're thinking about the fact that

play34:09

things can change and even though we

play34:11

think something isn't likely today 10 20

play34:13

25 years from now God only knows what

play34:16

could be possible so that part of it is

play34:17

is really really important and certainly

play34:19

for our young people considering careers

play34:21

and just think about the incredible

play34:23

benefit that medical research has across

play34:26

so many lives and so many individuals

play34:28

and if you really are in the the mode of

play34:30

wanting to make the world a better place

play34:31

and wanting to you know go home from

play34:33

work every day feeling like you made a

play34:35

difference in knowing that the work that

play34:37

you're doing is having tremendous value

play34:39

for other people this is a great career

play34:41

path for people to think about you know

play34:42

as you were answering that last question

play34:44

Julie it it brought to mind a a couple

play34:46

thoughts number one is years ago uh in

play34:49

one of our manufacturing companies we

play34:51

wanted to expand uh the number of

play34:54

quality instructors that we had and we

play34:56

wanted to find the best quality

play34:57

instructors we could and somebody came

play34:59

up with the bright idea of doing

play35:01

personality profiles on our best quality

play35:03

instructors and saying what personality

play35:06

traits were most important in somebody

play35:08

that could do that job really really

play35:10

well and then when we when we went to

play35:12

recruit train and promote individuals

play35:14

for that job we actually did personality

play35:17

profiles on candidates as well and

play35:18

matched those personality profiles with

play35:20

the ones that we knew were the most

play35:22

effective in terms of executing the

play35:23

responsibilities in that particular role

play35:25

within our company I'm kind of wondering

play35:28

and is the same thing true of of

play35:29

research I mean is is you're looking at

play35:31

people not just in terms of what their

play35:33

education background is or what their uh

play35:36

academic qualifications are but but also

play35:38

in terms of the types of people that

play35:40

excel in that space are there and you

play35:42

mentioned a couple already but Are there

play35:44

specific character traits that that you

play35:46

feel are really really important if a

play35:47

student is going to consider this career

play35:50

Endeavor you know I think being

play35:51

inquisitive or curious we call it

play35:53

scientific curiosity right because

play35:55

that's really what you're doing as your

play35:56

advancing Sciences you're constantly

play35:58

asking a question right and you're

play36:00

trying to understand and when there

play36:01

isn't an answer to that question then

play36:03

that's perhaps the are research that

play36:05

you're going to go because you're driven

play36:07

to try to find answers to those

play36:09

unanswered questions and so always being

play36:12

curious about the world around you is

play36:14

probably a big component um and I you

play36:17

know I talked a lot about being a

play36:19

quantitative thinker right you like to

play36:20

measure things you like evidence right

play36:23

that drives science is the data and the

play36:25

evidence behind you know decisions or

play36:27

reasons for uh recommendations I think

play36:31

if we think about it from a physician

play36:33

scientist standpoint and a phys where

play36:35

those worlds really Collide a lot you

play36:38

know it's really listening and I

play36:40

remember my dad saying this listening to

play36:42

the patient right because they're always

play36:44

right and they always know and I even

play36:45

learned this in Pediatrics listen to the

play36:47

parents and I think we forget that piece

play36:50

but that's another piece that will help

play36:51

you solve the puzzle right is if they're

play36:53

telling you something their disease is

play36:55

telling you something you need to listen

play36:57

you know closely and pick out um what

play37:00

can I do with that information where

play37:02

will that lead me and how can that lead

play37:04

me to advancing scientific discovery

play37:07

based on on what individuals are showing

play37:09

and CO's a great example of that we we

play37:11

just we really had to look and listen

play37:14

you know we very quickly learned

play37:16

patients were having lots of difficulty

play37:18

with clotting in an unbelievable ways

play37:20

and in unusual places and so that was

play37:22

that was to me

play37:24

fascinating a world of unknown and so

play37:27

you know get into the lab get down to

play37:28

the bench listen to the patients what

play37:30

are they showing you and take that back

play37:32

to the lab so that's I think a really

play37:34

fun piece so you're probably hearing the

play37:35

excitement um from that and that's how

play37:38

you get to advances in science it's

play37:40

often the opposite of what you think

play37:42

right it's the patient at the bedside

play37:43

that takes you to the bench and you then

play37:45

bring that Discovery back to them I know

play37:48

our educators are fascinated as they're

play37:50

listening to this conversation and of

play37:51

course we've got stem Educators all over

play37:53

the United States and around the globe

play37:55

that tune into the podcast every week to

play37:57

listen to the advice that comes from the

play38:00

wide range of guests that we that we are

play38:02

fortunate enough to have join us here on

play38:03

the teched podcast Julie and I want to

play38:05

turn as we kind of move toward the end

play38:07

of our conversation today a couple more

play38:09

questions left but but one that I think

play38:11

many of our Educators may have on their

play38:12

minds you know their job I'm a stem

play38:14

educator science technology engineering

play38:16

and math of course whether I'm at the

play38:18

the K12 level I'm in a community college

play38:20

I'm in an undergrad program a graduate

play38:22

program doctorate program what have you

play38:25

you know as our St educators are

play38:27

starting to think about what they're

play38:29

hearing today and also thinking about

play38:31

how they Inspire the next generation of

play38:33

Professionals in the world of healthcare

play38:35

what advice would you have for those

play38:37

yeah I think there's it's so important

play38:39

your Educators right and those that you

play38:41

encounter because it can be just one

play38:42

educator one teacher that can just spark

play38:45

that sort of energy in in a student to

play38:47

then go on and you know be a Nobel Prize

play38:50

winner right who knows but so I think

play38:52

that's what I remember and it was that

play38:53

biology class I think it was Sister

play38:55

Bernard

play38:57

right it was just like she had a way of

play38:59

really making it fascinating right and I

play39:01

think sharing your excitement and

play39:03

enthusiasm which I I'm guessing is

play39:06

really hard as an educator to do that

play39:08

year after year with maybe most of the

play39:10

students not really caring right they

play39:11

just have to get through it but for

play39:13

those you know that that are interested

play39:17

trying to keep that excitement

play39:18

enthusiasm for the science alive right I

play39:21

think you'll draw people in just

play39:23

naturally right so it really is their

play39:25

ability to to do that um at least it it

play39:28

was for me right so I I give a lot of

play39:31

credit to those Educators that I had

play39:33

early in my career for you and for many

play39:36

and we talk a lot quite a bit on this

play39:37

podcast about um I always ask people to

play39:41

think back to their education pathway

play39:43

whatever that was and everybody had

play39:45

their own version of it you know and

play39:47

pick your two or three favorite whether

play39:49

it was a teacher an instructor or

play39:50

Professor or whatever title that person

play39:52

had and upon reflection almost everybody

play39:55

will tell you that it wasn't the one

play39:57

that had the perfect lesson plan it

play39:59

wasn't the one that spent all the time

play40:00

over the summer coming up with the exact

play40:03

perfect way to teach Fillin the blank it

play40:05

was always somebody that said you know

play40:07

that showed that individual it was

play40:09

always an educator that showed that

play40:11

individual you know look you have a

play40:13

skill that you never knew that you had

play40:15

or an aptitude that you never knew that

play40:17

you had that you could uncover there

play40:18

here's an interest that you never

play40:20

explored before now you have this brand

play40:22

new interest or here's something that

play40:24

you never believe that you could do on

play40:26

your own never even thought about and

play40:28

then you had this this teacher this

play40:30

professor this instructor that showed

play40:32

you you were capable of being something

play40:33

that you didn't even know you could be

play40:35

and that really to me is the magic of

play40:38

Education to to spark that enthusiasm

play40:41

you know that that you point to in terms

play40:43

of showing a student that they could be

play40:45

something that maybe they weren't even

play40:46

thinking about and getting him excited

play40:48

you know in this case about the world of

play40:50

medicine but whatever that career path

play40:52

is so really really sound advice I think

play40:54

for our Educators that you offer here on

play40:56

the teched podcast we have time for one

play40:58

last question we always love this

play40:59

question we're gonna go back in time you

play41:01

already talked about a grandfather uh

play41:03

who was a medical professional your

play41:06

father of course and now here you are

play41:08

following in those amazing footsteps and

play41:11

and blazing a trail that I'm sure

play41:12

neither one of them years ago might have

play41:14

dreamed that that you would be on or

play41:15

that medicine in general would be on but

play41:17

I want to turn the clock back to when

play41:19

you're growing up in that environment

play41:20

and let's say you're a sophomore in high

play41:22

school and you could go back in time and

play41:24

and give that um young lady at least one

play41:27

piece of advice is you're thinking about

play41:29

that what would that piece of advice be

play41:31

yeah I love this question I think it

play41:33

would be think

play41:35

bigger if you're comfortable you're not

play41:38

thinking big enough right you need to

play41:40

feel some of that discomfort and push

play41:42

yourself that's what I would share and

play41:44

you don't really realize that I think do

play41:46

you get a bit older right absolutely and

play41:48

the world opens up a little bit more to

play41:50

you and all of a sudden you you know you

play41:52

realize that that there is this

play41:54

incredible planet Earth and these

play41:56

incredible opportunities and all these

play41:58

things that we can accomplish if we

play42:00

think big enough I would certainly

play42:02

suggest today Julie that that you're

play42:04

thinking big uh obviously the the career

play42:06

transition you've made in the last

play42:08

several years the the willingness to

play42:10

think even bigger than maybe some of the

play42:12

things that you've done in the past and

play42:14

and just the incredible impact that

play42:16

you're having on so many lives it's been

play42:18

a wonderful time for for you to join us

play42:21

here in the teched podcast I've really

play42:23

enjoyed our conversation Our Guest has

play42:25

been Dr Julie panap Pinto the director

play42:27

of the division of blood diseases and

play42:29

resources at the national heart lung and

play42:32

Blood Institute of the National

play42:34

Institutes of Health Julie wonderful

play42:36

conversation thank you so much for being

play42:38

here thank you

play42:40

Matt fascinating episode of the teched

play42:43

podcast with Dr Julie panipinto I

play42:45

learned so much and I feel so much

play42:47

smarter for having had that opportunity

play42:49

to have a conversation with an

play42:51

incredibly well recognized leader in the

play42:54

medical community so thanks so much much

play42:56

for joining us for this episode of the

play42:58

tech ad podcast as you know all of the

play43:00

show notes and all of the resources that

play43:03

you heard mentioned on this episode are

play43:06

going to be linked up in the show notes

play43:08

so be sure and visit that head on over

play43:10

to teched podcast.com this particular

play43:13

episode will be Tech ADP podcast.com

play43:16

panipinto and that is spelled p

play43:19

NE p i n t o that's where you'll find

play43:23

the show notes for this episode we have

play43:25

the best show notes in the business and

play43:27

you will find helpful information there

play43:30

every single week now don't forget we're

play43:31

active on every social media platform

play43:33

that you can think of including LinkedIn

play43:36

Facebook Instagram and Tik Tok posting

play43:39

all the time about new episodes and

play43:41

other great things happening in the

play43:43

world of technical education so find us

play43:45

on your favorite social platform and we

play43:48

would love to say hello to you and

play43:49

connect with you thanks so much for

play43:51

being with us this week on the teched

play43:55

podcast

Rate This
โ˜…
โ˜…
โ˜…
โ˜…
โ˜…

5.0 / 5 (0 votes)

Related Tags
Healthcare InnovationMedical ResearchData AnalyticsArtificial IntelligenceBlood DisordersPatient ExperienceSTEM CareersScientific DiscoveryPrecision MedicineNational InstitutesInspiring Interview